<p>Montecito Bank  Trust 在第三季度收購了 Thermo Fisher Scientific Inc.（紐約證券交易所代碼：TMO - 免費報告）的一項新股份，根據其最近向證券交易委員會提交的 13F 表格。該基金收購了 2,959 股這家醫療研究公司的股票，價值約為 1,435,000 美元。</p>
<ul>
<li>機構熱愛這三家公司，你也應該嗎？</li>
</ul>
<p>其他一些機構投資者也調整了他們對 TMO 的持股。新約定信託公司 N.A. 在第三季度購買了價值約 228,000 美元的 Thermo Fisher Scientific 股票的新股份。McLean Asset Management Corp 在第三季度將其在 Thermo Fisher Scientific 的持股增加了 4.7%。McLean Asset Management Corp 目前擁有 627 股這家醫療研究公司的股票，價值 304,000 美元，此前在此期間又購買了 28 股。Channel Wealth LLC 在第三季度購買了價值 210,000 美元的 Thermo Fisher Scientific 股票的新頭寸。ST Germain D J Co. Inc. 在第三季度將其在 Thermo Fisher Scientific 的持股增加了 7.7%。ST Germain D J Co. Inc. 目前擁有 3,947 股這家醫療研究公司的股票，價值 1,914,000 美元，此前在上個季度又收購了 281 股。最後，Grant Private Wealth Management Inc 在第三季度購買了價值約 457,000 美元的 Thermo Fisher Scientific 新股份。89.23% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>Thermo Fisher Scientific 股票表現</h2>
<p>TMO 的股票在週四開盤價為 562.58 美元。Thermo Fisher Scientific Inc. 的 12 個月低點為 385.46 美元，12 個月高點為 610.97 美元。該股票的 50 天移動平均價格為 567.63 美元，200 天移動平均價格為 495.07 美元。該公司的流動比率為 1.50，速動比率為 1.11，債務與股本比率為 0.62。該公司的市值為 2,113.7 億美元，市盈率為 32.50，市盈增長比率為 4.22，貝塔值為 0.90。</p>
<ul>
<li>這三隻股票通過回購來傳遞市場信心</li>
</ul>
<p>Thermo Fisher Scientific（紐約證券交易所代碼：TMO - 獲取免費報告）最近在 10 月 22 日（星期三）公佈了其財報。這家醫療研究公司報告的每股收益（EPS）為 5.79 美元，超出市場共識預期的 5.50 美元，超出幅度為 0.29 美元。該公司在本季度的收入為 111.2 億美元，而分析師預期為 109 億美元。Thermo Fisher Scientific 的股本回報率為 16.97%，淨利潤率為 15.02%。該公司的季度收入較去年同期增長了 4.9%。在去年同期，該公司發佈的每股收益為 5.28 美元。Thermo Fisher Scientific 將其 2025 財年的指導目標設定為 22.600-22.860 每股收益。股票研究分析師預測，Thermo Fisher Scientific Inc. 本財年的每股收益將達到 23.28 美元。</p>
<p>Thermo Fisher Scientific 宣佈其董事會已於 11 月 6 日（星期四）啓動了一項股票回購計劃，允許公司回購價值 50 億美元的股票。該回購授權允許這家醫療研究公司通過公開市場購買回購最多 2.4% 的股票。股票回購計劃通常表明公司的領導層認為其股票被低估。</p>
<h2>Thermo Fisher Scientific 股息公告</h2>
<ul>
<li>現金流關注：Thermo Fisher、能源轉移和網易</li>
</ul>
<p>該公司還最近宣佈了一項季度股息，將於 1 月 15 日（星期四）支付。12 月 15 日（星期一）的登記投資者將獲得 0.43 美元的股息。除息日期為 12 月 15 日（星期一）。這代表着年化股息為 1.72 美元，收益率為 0.3%。Thermo Fisher Scientific 的股息支付比率（DPR）為 9.94%。</p>
<h2>Thermo Fisher Scientific 內部活動</h2>
<p>在相關消息中，首席運營官 Michel Lagarde 於 12 月 4 日（星期四）出售了 22,046 股公司的股票。該股票以平均價格 563.56 美元出售，總價值為 12,424,243.76 美元。交易後，首席運營官直接持有 84,117 股公司的股票，價值 47,404,976.52 美元。這代表着其持股減少了 20.77%。該交易已在證券交易委員會的法律文件中披露，相關信息可在此鏈接查看。此外，副總裁 Lisa P. Britt 於 11 月 12 日（星期三）出售了 1,058 股 Thermo Fisher Scientific 股票。該股票以平均價格 588.26 美元出售，總價值為 622,379.08 美元。出售後，副總裁直接持有 13,087 股公司的股票，價值約 7,698,558.62 美元。這代表着其持股減少了 7.48%。該銷售的 SEC 文件提供了更多信息。過去 90 天內，內部人士已出售價值 86,507,282 美元的 149,271 股公司股票。0.33% 的股票由內部人士持有。</p>
<h2>華爾街分析師觀點</h2>
<p>TMO 最近成為幾份研究報告的主題。Weiss Ratings 在 10 月 14 日的報告中重申了對賽默飛世爾股票的 &#34;持有 (c)&#34; 評級。摩根士丹利在 12 月 2 日的研究報告中將賽默飛世爾的目標價格從 656.00 美元上調至 670.00 美元，並給予該股票 &#34;超配&#34; 評級。花旗集團在 12 月 11 日的研究報告中將賽默飛世爾的評級從 &#34;中性&#34; 上調至 &#34;買入&#34;，並將其目標價格從 580.00 美元提高至 660.00 美元。Evercore ISI 在 10 月 7 日的研究報告中將賽默飛世爾的目標價格從 525.00 美元上調至 590.00 美元，並給予該股票 &#34;跑贏大盤&#34; 評級。最後，滙豐全球研究在 12 月 1 日的研究報告中將賽默飛世爾的評級從 &#34;持有&#34; 上調至 &#34;強烈買入&#34;。一位研究分析師給予該股票 &#34;強烈買入&#34; 評級，二十位分析師給予 &#34;買入&#34; 評級，三位分析師給予 &#34;持有&#34; 評級。根據 MarketBeat.com 的數據，賽默飛世爾的平均評級為 &#34;適度買入&#34;，平均目標價格為 616.60 美元。</p>
<p><strong>閲讀我們關於 TMO 的最新研究報告</strong></p>
<h2>賽默飛世爾公司簡介</h2>
<p>(免費報告)</p>
<p>賽默飛世爾科技公司在北美、歐洲、亞太及國際市場提供生命科學解決方案、分析儀器、專業診斷、實驗室產品和生物製藥服務。公司的生命科學解決方案部門為生物和醫學研究、藥物和疫苗的發現與生產以及感染和疾病的診斷提供試劑、儀器和耗材；解決方案包括生物科學、遺傳科學和生物生產，服務於製藥、生物技術、農業、臨牀、醫療保健、學術和政府市場。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們認為比賽默飛世爾更好的股票</li>
<li>現在買入寶潔公司，趁其創下新高之前</li>
<li>在上漲 35% 後，分析師關注銅業巨頭自由港的更多上漲空間</li>
<li>零售投資者如何交易多倫多證券交易所 (TSX)？</li>
<li>為什麼 SpaceX 的 IPO 可能成為 GOOGL 股票的重大催化劑</li>
<li>萬億美元市值的意義超越了一個數字</li>
<li>Upwork 能否維持其復甦？看漲和看跌的理由</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在賽默飛世爾嗎？</h2>
<p>在你考慮賽默飛世爾之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而賽默飛世爾並不在名單上。</p>
<p>雖然賽默飛世爾目前在分析師中獲得 &#34;適度買入&#34; 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

賽默飛世爾

<p>Montecito Bank & Trust 在第三季度收購了 2,959 股賽默飛世爾，價值 1,435,000 美元。其他機構投資者也調整了他們的持股。賽默飛世爾的股票開盤價為 562.58 美元，市值為 2,113.7 億美元。該公司報告了本季度每股收益為 5.79 美元，超出預期。公司啓動了一項 50 億美元的股票回購計劃，並宣佈了每季度 0.43 美元的股息。內部人士銷售包括首席運營官 Michel Lagarde 出售了 22,046 股</p>

<p>Montecito Bank &amp; Trust acquired a new stake in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 2,959 shares of the medical research company's stock, valued at approximately $1,435,000.</p>
<div class="lb-trans"><p>Montecito Bank  Trust 在第三季度收購了 Thermo Fisher Scientific Inc.（紐約證券交易所代碼：TMO - 免費報告）的一項新股份，根據其最近向證券交易委員會提交的 13F 表格。該基金收購了 2,959 股這家醫療研究公司的股票，價值約為 1,435,000 美元。</p>
</div><ul>
<li>Institutions Love These 3 Companies, Should You As Well?</li>
</ul>
<div class="lb-trans"><ul>
<li>機構熱愛這三家公司，你也應該嗎？</li>
</ul>
</div><p>A number of other institutional investors have also modified their holdings of TMO. New Covenant Trust Company N.A. purchased a new stake in shares of Thermo Fisher Scientific in the third quarter valued at approximately $228,000. McLean Asset Management Corp lifted its holdings in shares of Thermo Fisher Scientific by 4.7% in the 3rd quarter. McLean Asset Management Corp now owns 627 shares of the medical research company's stock worth $304,000 after buying an additional 28 shares during the period. Channel Wealth LLC bought a new position in shares of Thermo Fisher Scientific during the 3rd quarter worth $210,000. ST Germain D J Co. Inc. raised its holdings in shares of Thermo Fisher Scientific by 7.7% in the third quarter. ST Germain D J Co. Inc. now owns 3,947 shares of the medical research company's stock valued at $1,914,000 after acquiring an additional 281 shares in the last quarter. Finally, Grant Private Wealth Management Inc purchased a new stake in Thermo Fisher Scientific in the third quarter worth about $457,000. 89.23% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他一些機構投資者也調整了他們對 TMO 的持股。新約定信託公司 N.A. 在第三季度購買了價值約 228,000 美元的 Thermo Fisher Scientific 股票的新股份。McLean Asset Management Corp 在第三季度將其在 Thermo Fisher Scientific 的持股增加了 4.7%。McLean Asset Management Corp 目前擁有 627 股這家醫療研究公司的股票，價值 304,000 美元，此前在此期間又購買了 28 股。Channel Wealth LLC 在第三季度購買了價值 210,000 美元的 Thermo Fisher Scientific 股票的新頭寸。ST Germain D J Co. Inc. 在第三季度將其在 Thermo Fisher Scientific 的持股增加了 7.7%。ST Germain D J Co. Inc. 目前擁有 3,947 股這家醫療研究公司的股票，價值 1,914,000 美元，此前在上個季度又收購了 281 股。最後，Grant Private Wealth Management Inc 在第三季度購買了價值約 457,000 美元的 Thermo Fisher Scientific 新股份。89.23% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>Thermo Fisher Scientific Stock Performance</h2>
<div class="lb-trans"><h2>Thermo Fisher Scientific 股票表現</h2>
</div><p>Shares of TMO opened at $562.58 on Thursday. Thermo Fisher Scientific Inc. has a 12 month low of $385.46 and a 12 month high of $610.97. The stock has a fifty day moving average price of $567.63 and a 200-day moving average price of $495.07. The company has a current ratio of 1.50, a quick ratio of 1.11 and a debt-to-equity ratio of 0.62. The firm has a market cap of $211.37 billion, a PE ratio of 32.50, a P/E/G ratio of 4.22 and a beta of 0.90.</p>
<div class="lb-trans"><p>TMO 的股票在週四開盤價為 562.58 美元。Thermo Fisher Scientific Inc. 的 12 個月低點為 385.46 美元，12 個月高點為 610.97 美元。該股票的 50 天移動平均價格為 567.63 美元，200 天移動平均價格為 495.07 美元。該公司的流動比率為 1.50，速動比率為 1.11，債務與股本比率為 0.62。該公司的市值為 2,113.7 億美元，市盈率為 32.50，市盈增長比率為 4.22，貝塔值為 0.90。</p>
</div><ul>
<li>These 3 Stocks Are Using Buybacks to Signal Market Confidence</li>
</ul>
<div class="lb-trans"><ul>
<li>這三隻股票通過回購來傳遞市場信心</li>
</ul>
</div><p>Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last announced its earnings results on Wednesday, October 22nd. The medical research company reported $5.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.50 by $0.29. The company had revenue of $11.12 billion for the quarter, compared to analyst estimates of $10.90 billion. Thermo Fisher Scientific had a return on equity of 16.97% and a net margin of 15.02%.The firm's quarterly revenue was up 4.9% compared to the same quarter last year. During the same period in the prior year, the company posted $5.28 EPS. Thermo Fisher Scientific has set its FY 2025 guidance at 22.600-22.860 EPS. Equities research analysts predict that Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Thermo Fisher Scientific（紐約證券交易所代碼：TMO - 獲取免費報告）最近在 10 月 22 日（星期三）公佈了其財報。這家醫療研究公司報告的每股收益（EPS）為 5.79 美元，超出市場共識預期的 5.50 美元，超出幅度為 0.29 美元。該公司在本季度的收入為 111.2 億美元，而分析師預期為 109 億美元。Thermo Fisher Scientific 的股本回報率為 16.97%，淨利潤率為 15.02%。該公司的季度收入較去年同期增長了 4.9%。在去年同期，該公司發佈的每股收益為 5.28 美元。Thermo Fisher Scientific 將其 2025 財年的指導目標設定為 22.600-22.860 每股收益。股票研究分析師預測，Thermo Fisher Scientific Inc. 本財年的每股收益將達到 23.28 美元。</p>
</div><p>Thermo Fisher Scientific declared that its Board of Directors has initiated a stock repurchase program on Thursday, November 6th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the medical research company to repurchase up to 2.4% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company's leadership believes its stock is undervalued.</p>
<div class="lb-trans"><p>Thermo Fisher Scientific 宣佈其董事會已於 11 月 6 日（星期四）啓動了一項股票回購計劃，允許公司回購價值 50 億美元的股票。該回購授權允許這家醫療研究公司通過公開市場購買回購最多 2.4% 的股票。股票回購計劃通常表明公司的領導層認為其股票被低估。</p>
</div><h2>Thermo Fisher Scientific Dividend Announcement</h2>
<div class="lb-trans"><h2>Thermo Fisher Scientific 股息公告</h2>
</div><ul>
<li>Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase</li>
</ul>
<div class="lb-trans"><ul>
<li>現金流關注：Thermo Fisher、能源轉移和網易</li>
</ul>
</div><p>The business also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Monday, December 15th will be paid a $0.43 dividend. The ex-dividend date is Monday, December 15th. This represents a $1.72 dividend on an annualized basis and a yield of 0.3%. Thermo Fisher Scientific's dividend payout ratio (DPR) is 9.94%.</p>
<div class="lb-trans"><p>該公司還最近宣佈了一項季度股息，將於 1 月 15 日（星期四）支付。12 月 15 日（星期一）的登記投資者將獲得 0.43 美元的股息。除息日期為 12 月 15 日（星期一）。這代表着年化股息為 1.72 美元，收益率為 0.3%。Thermo Fisher Scientific 的股息支付比率（DPR）為 9.94%。</p>
</div><h2>Insider Activity at Thermo Fisher Scientific</h2>
<div class="lb-trans"><h2>Thermo Fisher Scientific 內部活動</h2>
</div><p>In related news, COO Michel Lagarde sold 22,046 shares of the company's stock in a transaction on Thursday, December 4th. The stock was sold at an average price of $563.56, for a total value of $12,424,243.76. Following the transaction, the chief operating officer directly owned 84,117 shares of the company's stock, valued at $47,404,976.52. This represents a 20.77% decrease in their position. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available at this hyperlink. Also, VP Lisa P. Britt sold 1,058 shares of Thermo Fisher Scientific stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $588.26, for a total value of $622,379.08. Following the sale, the vice president directly owned 13,087 shares of the company's stock, valued at approximately $7,698,558.62. This represents a 7.48% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 149,271 shares of company stock worth $86,507,282 in the last 90 days. 0.33% of the stock is owned by insiders.</p>
<div class="lb-trans"><p>在相關消息中，首席運營官 Michel Lagarde 於 12 月 4 日（星期四）出售了 22,046 股公司的股票。該股票以平均價格 563.56 美元出售，總價值為 12,424,243.76 美元。交易後，首席運營官直接持有 84,117 股公司的股票，價值 47,404,976.52 美元。這代表着其持股減少了 20.77%。該交易已在證券交易委員會的法律文件中披露，相關信息可在此鏈接查看。此外，副總裁 Lisa P. Britt 於 11 月 12 日（星期三）出售了 1,058 股 Thermo Fisher Scientific 股票。該股票以平均價格 588.26 美元出售，總價值為 622,379.08 美元。出售後，副總裁直接持有 13,087 股公司的股票，價值約 7,698,558.62 美元。這代表着其持股減少了 7.48%。該銷售的 SEC 文件提供了更多信息。過去 90 天內，內部人士已出售價值 86,507,282 美元的 149,271 股公司股票。0.33% 的股票由內部人士持有。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><p>TMO has been the subject of several recent research reports. Weiss Ratings restated a &#34;hold (c)&#34; rating on shares of Thermo Fisher Scientific in a report on Tuesday, October 14th. Morgan Stanley boosted their price objective on shares of Thermo Fisher Scientific from $656.00 to $670.00 and gave the stock an &#34;overweight&#34; rating in a research note on Tuesday, December 2nd. Citigroup raised Thermo Fisher Scientific from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and increased their target price for the company from $580.00 to $660.00 in a research report on Thursday, December 11th. Evercore ISI boosted their price target on Thermo Fisher Scientific from $525.00 to $590.00 and gave the stock an &#34;outperform&#34; rating in a research report on Tuesday, October 7th. Finally, Hsbc Global Res upgraded Thermo Fisher Scientific from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Monday, December 1st. One research analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Thermo Fisher Scientific has an average rating of &#34;Moderate Buy&#34; and an average target price of $616.60.</p>
<div class="lb-trans"><p>TMO 最近成為幾份研究報告的主題。Weiss Ratings 在 10 月 14 日的報告中重申了對賽默飛世爾股票的 &#34;持有 (c)&#34; 評級。摩根士丹利在 12 月 2 日的研究報告中將賽默飛世爾的目標價格從 656.00 美元上調至 670.00 美元，並給予該股票 &#34;超配&#34; 評級。花旗集團在 12 月 11 日的研究報告中將賽默飛世爾的評級從 &#34;中性&#34; 上調至 &#34;買入&#34;，並將其目標價格從 580.00 美元提高至 660.00 美元。Evercore ISI 在 10 月 7 日的研究報告中將賽默飛世爾的目標價格從 525.00 美元上調至 590.00 美元，並給予該股票 &#34;跑贏大盤&#34; 評級。最後，滙豐全球研究在 12 月 1 日的研究報告中將賽默飛世爾的評級從 &#34;持有&#34; 上調至 &#34;強烈買入&#34;。一位研究分析師給予該股票 &#34;強烈買入&#34; 評級，二十位分析師給予 &#34;買入&#34; 評級，三位分析師給予 &#34;持有&#34; 評級。根據 MarketBeat.com 的數據，賽默飛世爾的平均評級為 &#34;適度買入&#34;，平均目標價格為 616.60 美元。</p>
</div><p><strong>Read Our Latest Research Report on TMO</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 TMO 的最新研究報告</strong></p>
</div><h2>Thermo Fisher Scientific Profile</h2>
<div class="lb-trans"><h2>賽默飛世爾公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.</p>
<div class="lb-trans"><p>賽默飛世爾科技公司在北美、歐洲、亞太及國際市場提供生命科學解決方案、分析儀器、專業診斷、實驗室產品和生物製藥服務。公司的生命科學解決方案部門為生物和醫學研究、藥物和疫苗的發現與生產以及感染和疾病的診斷提供試劑、儀器和耗材；解決方案包括生物科學、遺傳科學和生物生產，服務於製藥、生物技術、農業、臨牀、醫療保健、學術和政府市場。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Thermo Fisher Scientific</li>
<li>Buy P&amp;G Now, Before It Sets A New All-Time High</li>
<li>Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport</li>
<li>How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?</li>
<li>Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock</li>
<li>The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number</li>
<li>Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比賽默飛世爾更好的股票</li>
<li>現在買入寶潔公司，趁其創下新高之前</li>
<li>在上漲 35% 後，分析師關注銅業巨頭自由港的更多上漲空間</li>
<li>零售投資者如何交易多倫多證券交易所 (TSX)？</li>
<li>為什麼 SpaceX 的 IPO 可能成為 GOOGL 股票的重大催化劑</li>
<li>萬億美元市值的意義超越了一個數字</li>
<li>Upwork 能否維持其復甦？看漲和看跌的理由</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=TMO"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Thermo Fisher Scientific Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在賽默飛世爾嗎？</h2>
</div><p>Before you consider Thermo Fisher Scientific, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮賽默飛世爾之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thermo Fisher Scientific wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而賽默飛世爾並不在名單上。</p>
</div><p>While Thermo Fisher Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然賽默飛世爾目前在分析師中獲得 &#34;適度買入&#34; 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Montecito Bank & Trust 購入了 2,959 股賽默飛世爾科技公司股票 $TMO